| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernias, Diaphragmatic, Congenital | 43 | 2025 | 401 | 9.000 |
Why?
|
| Enterocolitis, Necrotizing | 17 | 2025 | 257 | 5.320 |
Why?
|
| Prenatal Diagnosis | 38 | 2024 | 609 | 4.050 |
Why?
|
| Fetal Diseases | 22 | 2024 | 437 | 3.460 |
Why?
|
| Wound Healing | 16 | 2025 | 485 | 3.390 |
Why?
|
| Fetoscopy | 18 | 2024 | 458 | 2.880 |
Why?
|
| Hernia, Umbilical | 6 | 2023 | 40 | 2.640 |
Why?
|
| Infant, Newborn | 90 | 2026 | 8523 | 2.550 |
Why?
|
| Spectroscopy, Near-Infrared | 6 | 2017 | 156 | 2.450 |
Why?
|
| Keloid | 4 | 2024 | 11 | 2.290 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2025 | 37 | 2.220 |
Why?
|
| Pregnancy | 79 | 2024 | 7386 | 2.210 |
Why?
|
| Ultrasonography, Prenatal | 29 | 2026 | 968 | 2.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 21 | 2024 | 678 | 2.120 |
Why?
|
| Oxygen | 8 | 2025 | 550 | 2.000 |
Why?
|
| Lung | 23 | 2025 | 1533 | 1.990 |
Why?
|
| Infant, Premature, Diseases | 5 | 2025 | 252 | 1.980 |
Why?
|
| Fetus | 11 | 2023 | 566 | 1.920 |
Why?
|
| Cicatrix, Hypertrophic | 3 | 2023 | 6 | 1.890 |
Why?
|
| Fetal Therapies | 9 | 2024 | 94 | 1.730 |
Why?
|
| Hernia, Diaphragmatic | 11 | 2014 | 91 | 1.710 |
Why?
|
| Retrospective Studies | 79 | 2026 | 17493 | 1.620 |
Why?
|
| Teratoma | 9 | 2023 | 120 | 1.570 |
Why?
|
| Isoflurane | 3 | 2018 | 35 | 1.480 |
Why?
|
| Heart Defects, Congenital | 6 | 2026 | 1870 | 1.460 |
Why?
|
| Duodenal Obstruction | 3 | 2026 | 13 | 1.420 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2020 | 3747 | 1.400 |
Why?
|
| Female | 125 | 2026 | 70308 | 1.320 |
Why?
|
| Humans | 172 | 2026 | 130350 | 1.310 |
Why?
|
| Meningomyelocele | 7 | 2019 | 255 | 1.290 |
Why?
|
| Cicatrix | 5 | 2024 | 125 | 1.280 |
Why?
|
| Gestational Age | 19 | 2024 | 1206 | 1.210 |
Why?
|
| Perinatal Care | 4 | 2020 | 65 | 1.180 |
Why?
|
| Urethral Obstruction | 4 | 2024 | 55 | 1.130 |
Why?
|
| Swine | 23 | 2024 | 1184 | 1.110 |
Why?
|
| Wounds and Injuries | 4 | 2024 | 392 | 1.110 |
Why?
|
| Intestines | 7 | 2016 | 587 | 1.090 |
Why?
|
| Brain | 6 | 2019 | 3173 | 1.080 |
Why?
|
| Surgeons | 5 | 2023 | 288 | 1.070 |
Why?
|
| Trachea | 5 | 2024 | 206 | 1.040 |
Why?
|
| Lung Diseases | 9 | 2022 | 395 | 0.960 |
Why?
|
| Preoperative Care | 3 | 2026 | 357 | 0.940 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 4 | 2022 | 18 | 0.930 |
Why?
|
| Apoptosis | 3 | 2018 | 1829 | 0.930 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 964 | 0.910 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2023 | 177 | 0.860 |
Why?
|
| Splanchnic Circulation | 2 | 2015 | 49 | 0.860 |
Why?
|
| Ischemic Preconditioning | 1 | 2024 | 22 | 0.860 |
Why?
|
| Liver | 9 | 2022 | 1788 | 0.840 |
Why?
|
| Twins, Conjoined | 3 | 2020 | 29 | 0.820 |
Why?
|
| Hydrops Fetalis | 9 | 2020 | 82 | 0.810 |
Why?
|
| Male | 77 | 2026 | 64440 | 0.800 |
Why?
|
| Accountable Care Organizations | 1 | 2023 | 6 | 0.790 |
Why?
|
| Parenteral Nutrition | 10 | 2021 | 218 | 0.790 |
Why?
|
| Treatment Outcome | 40 | 2024 | 12834 | 0.780 |
Why?
|
| Echocardiography | 5 | 2026 | 1127 | 0.770 |
Why?
|
| Academic Success | 1 | 2023 | 22 | 0.770 |
Why?
|
| Abdominal Wall | 1 | 2022 | 26 | 0.750 |
Why?
|
| Obstetric Labor, Premature | 1 | 2023 | 76 | 0.750 |
Why?
|
| Consensus | 2 | 2024 | 528 | 0.730 |
Why?
|
| Biomarkers | 7 | 2025 | 3381 | 0.730 |
Why?
|
| Awards and Prizes | 1 | 2023 | 62 | 0.730 |
Why?
|
| Hydroxyurea | 1 | 2022 | 88 | 0.720 |
Why?
|
| Hypertension, Pulmonary | 9 | 2025 | 453 | 0.710 |
Why?
|
| Animals, Newborn | 15 | 2024 | 1015 | 0.710 |
Why?
|
| Disease Models, Animal | 13 | 2026 | 4666 | 0.710 |
Why?
|
| Appendicitis | 1 | 2023 | 132 | 0.710 |
Why?
|
| Sacrococcygeal Region | 4 | 2023 | 36 | 0.700 |
Why?
|
| Lasers, Gas | 1 | 2021 | 6 | 0.700 |
Why?
|
| Animals | 43 | 2026 | 33839 | 0.680 |
Why?
|
| Perioperative Care | 1 | 2023 | 220 | 0.680 |
Why?
|
| Infant | 33 | 2024 | 13240 | 0.670 |
Why?
|
| Sensitivity and Specificity | 8 | 2026 | 2087 | 0.660 |
Why?
|
| Hospitals, Pediatric | 4 | 2023 | 797 | 0.660 |
Why?
|
| Serum Amyloid P-Component | 2 | 2012 | 14 | 0.640 |
Why?
|
| Biomedical Research | 2 | 2023 | 562 | 0.630 |
Why?
|
| Infant, Premature | 10 | 2025 | 858 | 0.630 |
Why?
|
| Pneumonectomy | 3 | 2018 | 154 | 0.620 |
Why?
|
| Time-to-Treatment | 2 | 2018 | 210 | 0.610 |
Why?
|
| Pregnancy Outcome | 13 | 2017 | 611 | 0.610 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2015 | 66 | 0.610 |
Why?
|
| Anemia, Sickle Cell | 2 | 2022 | 331 | 0.610 |
Why?
|
| Umbilical Cord | 4 | 2022 | 54 | 0.610 |
Why?
|
| Surgical Procedures, Operative | 3 | 2018 | 225 | 0.600 |
Why?
|
| Fetal Death | 4 | 2015 | 114 | 0.580 |
Why?
|
| Predictive Value of Tests | 15 | 2026 | 2290 | 0.580 |
Why?
|
| Tissue Expansion | 1 | 2018 | 12 | 0.570 |
Why?
|
| Patient Simulation | 1 | 2018 | 41 | 0.560 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 337 | 0.550 |
Why?
|
| Sheep | 1 | 2018 | 219 | 0.550 |
Why?
|
| Elective Surgical Procedures | 2 | 2018 | 163 | 0.540 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2018 | 20 | 0.540 |
Why?
|
| Herniorrhaphy | 4 | 2023 | 72 | 0.520 |
Why?
|
| Kidney | 3 | 2019 | 1277 | 0.520 |
Why?
|
| Anuria | 1 | 2017 | 13 | 0.510 |
Why?
|
| Enteral Nutrition | 7 | 2021 | 285 | 0.500 |
Why?
|
| Anesthetics | 1 | 2017 | 75 | 0.490 |
Why?
|
| Lung Volume Measurements | 4 | 2014 | 72 | 0.490 |
Why?
|
| Education, Medical | 2 | 2018 | 292 | 0.490 |
Why?
|
| Prognosis | 17 | 2020 | 4860 | 0.480 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2016 | 5 | 0.480 |
Why?
|
| Neutrophil Infiltration | 2 | 2007 | 63 | 0.480 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 369 | 0.480 |
Why?
|
| Survival Rate | 9 | 2018 | 2112 | 0.470 |
Why?
|
| Incidence | 7 | 2024 | 3313 | 0.470 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2015 | 82 | 0.470 |
Why?
|
| Tracheoesophageal Fistula | 2 | 2006 | 48 | 0.470 |
Why?
|
| Respiratory System Abnormalities | 4 | 2022 | 42 | 0.460 |
Why?
|
| Simulation Training | 1 | 2018 | 170 | 0.460 |
Why?
|
| Anesthetics, Inhalation | 1 | 2015 | 41 | 0.460 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 307 | 0.460 |
Why?
|
| Pentalogy of Cantrell | 1 | 2015 | 2 | 0.450 |
Why?
|
| Child | 24 | 2023 | 26096 | 0.450 |
Why?
|
| Neurophysiological Monitoring | 1 | 2015 | 37 | 0.450 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 20 | 0.440 |
Why?
|
| Severity of Illness Index | 11 | 2024 | 3030 | 0.440 |
Why?
|
| Dexmedetomidine | 1 | 2015 | 47 | 0.440 |
Why?
|
| Postoperative Complications | 9 | 2020 | 3120 | 0.440 |
Why?
|
| Esophageal Atresia | 3 | 2014 | 52 | 0.430 |
Why?
|
| Premature Birth | 9 | 2021 | 419 | 0.430 |
Why?
|
| Abdomen | 1 | 2015 | 128 | 0.430 |
Why?
|
| Urinary Bladder Neck Obstruction | 3 | 2024 | 25 | 0.420 |
Why?
|
| Nitric Oxide | 3 | 2023 | 465 | 0.420 |
Why?
|
| Endothelial Cells | 3 | 2023 | 521 | 0.420 |
Why?
|
| Prenatal Care | 4 | 2023 | 344 | 0.410 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 1547 | 0.410 |
Why?
|
| Patient Safety | 1 | 2018 | 445 | 0.410 |
Why?
|
| Hypoxia | 1 | 2015 | 247 | 0.410 |
Why?
|
| Texas | 13 | 2019 | 3641 | 0.410 |
Why?
|
| Protein Biosynthesis | 3 | 2021 | 572 | 0.400 |
Why?
|
| Fetal Organ Maturity | 1 | 2013 | 8 | 0.400 |
Why?
|
| Horse Diseases | 1 | 2013 | 35 | 0.400 |
Why?
|
| Diagnosis, Differential | 6 | 2025 | 1876 | 0.380 |
Why?
|
| Head and Neck Neoplasms | 3 | 2015 | 631 | 0.370 |
Why?
|
| Dermis | 2 | 2013 | 25 | 0.370 |
Why?
|
| Digestive System Abnormalities | 2 | 2018 | 38 | 0.370 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 505 | 0.370 |
Why?
|
| Ear, External | 1 | 2012 | 25 | 0.360 |
Why?
|
| Catheter Ablation | 1 | 2015 | 321 | 0.360 |
Why?
|
| Glucagon-Like Peptide 2 | 4 | 2019 | 55 | 0.350 |
Why?
|
| Models, Animal | 4 | 2021 | 451 | 0.350 |
Why?
|
| Leydig Cell Tumor | 1 | 2011 | 7 | 0.350 |
Why?
|
| Interleukin-10 | 2 | 2023 | 187 | 0.340 |
Why?
|
| Image Enhancement | 1 | 2012 | 160 | 0.340 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 122 | 0.340 |
Why?
|
| Random Allocation | 4 | 2024 | 414 | 0.330 |
Why?
|
| Intestinal Mucosa | 5 | 2026 | 762 | 0.330 |
Why?
|
| Phytosterols | 3 | 2021 | 28 | 0.330 |
Why?
|
| Referral and Consultation | 3 | 2023 | 552 | 0.330 |
Why?
|
| P-Selectin | 2 | 2008 | 69 | 0.330 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 353 | 0.330 |
Why?
|
| Acute Disease | 2 | 2024 | 1147 | 0.320 |
Why?
|
| Sildenafil Citrate | 2 | 2022 | 56 | 0.320 |
Why?
|
| Tumor Burden | 1 | 2011 | 235 | 0.320 |
Why?
|
| Sus scrofa | 3 | 2020 | 112 | 0.320 |
Why?
|
| Urinary Bladder | 3 | 2017 | 219 | 0.320 |
Why?
|
| Skin | 2 | 2023 | 536 | 0.320 |
Why?
|
| Carbon Dioxide | 4 | 2021 | 270 | 0.310 |
Why?
|
| ROC Curve | 4 | 2017 | 610 | 0.310 |
Why?
|
| Liver Diseases | 5 | 2020 | 379 | 0.310 |
Why?
|
| Wilms Tumor | 2 | 2008 | 117 | 0.300 |
Why?
|
| Short Bowel Syndrome | 3 | 2020 | 61 | 0.300 |
Why?
|
| Vasodilator Agents | 2 | 2023 | 198 | 0.300 |
Why?
|
| Global Health | 3 | 2021 | 627 | 0.290 |
Why?
|
| Airway Management | 2 | 2024 | 67 | 0.290 |
Why?
|
| Hysterotomy | 4 | 2017 | 128 | 0.280 |
Why?
|
| Soybean Oil | 6 | 2021 | 71 | 0.280 |
Why?
|
| Models, Anatomic | 2 | 2020 | 106 | 0.280 |
Why?
|
| Printing, Three-Dimensional | 2 | 2020 | 87 | 0.280 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2008 | 10 | 0.280 |
Why?
|
| Cholestasis | 2 | 2021 | 170 | 0.280 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1594 | 0.280 |
Why?
|
| Stomach Volvulus | 1 | 2008 | 1 | 0.280 |
Why?
|
| Laparoscopy | 4 | 2016 | 535 | 0.280 |
Why?
|
| Phenyl Ethers | 2 | 2025 | 12 | 0.280 |
Why?
|
| Fetal Heart | 3 | 2018 | 131 | 0.280 |
Why?
|
| Spinal Neoplasms | 2 | 2011 | 78 | 0.280 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2019 | 161 | 0.270 |
Why?
|
| Fibroblasts | 1 | 2012 | 852 | 0.270 |
Why?
|
| Quality of Life | 6 | 2022 | 2074 | 0.270 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 91 | 0.270 |
Why?
|
| Thoracoscopy | 1 | 2008 | 41 | 0.270 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 67 | 0.260 |
Why?
|
| Thorax | 2 | 2021 | 65 | 0.260 |
Why?
|
| Skin Care | 1 | 2007 | 14 | 0.260 |
Why?
|
| United States | 10 | 2023 | 11866 | 0.260 |
Why?
|
| Cohort Studies | 8 | 2021 | 5038 | 0.260 |
Why?
|
| Disease Management | 1 | 2011 | 555 | 0.260 |
Why?
|
| Adult | 26 | 2020 | 31094 | 0.260 |
Why?
|
| Organ Size | 3 | 2019 | 410 | 0.250 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2024 | 347 | 0.250 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2019 | 122 | 0.250 |
Why?
|
| Bandages | 1 | 2007 | 52 | 0.250 |
Why?
|
| General Surgery | 4 | 2021 | 225 | 0.250 |
Why?
|
| Fish Oils | 5 | 2021 | 82 | 0.250 |
Why?
|
| Neovascularization, Physiologic | 2 | 2025 | 196 | 0.250 |
Why?
|
| Kidney Neoplasms | 2 | 2008 | 420 | 0.240 |
Why?
|
| Risk Assessment | 8 | 2022 | 3671 | 0.240 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2006 | 6 | 0.240 |
Why?
|
| Intubation, Intratracheal | 2 | 2024 | 287 | 0.240 |
Why?
|
| Phlebotomy | 1 | 2006 | 20 | 0.240 |
Why?
|
| Fat Emulsions, Intravenous | 3 | 2021 | 81 | 0.240 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 1001 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 625 | 0.240 |
Why?
|
| Airway Obstruction | 3 | 2013 | 173 | 0.240 |
Why?
|
| Mitomycin | 1 | 2006 | 39 | 0.240 |
Why?
|
| Esophageal Stenosis | 1 | 2006 | 45 | 0.240 |
Why?
|
| Streptococcus pyogenes | 1 | 2006 | 83 | 0.240 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2023 | 135 | 0.240 |
Why?
|
| Burns, Chemical | 1 | 2006 | 31 | 0.240 |
Why?
|
| Hirschsprung Disease | 1 | 2026 | 38 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2025 | 330 | 0.230 |
Why?
|
| Sheep, Domestic | 2 | 2015 | 17 | 0.230 |
Why?
|
| Subclavian Artery | 1 | 2006 | 64 | 0.230 |
Why?
|
| Urinary Tract | 2 | 2016 | 54 | 0.230 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 372 | 0.230 |
Why?
|
| Pericardium | 2 | 2017 | 103 | 0.230 |
Why?
|
| Thoracotomy | 1 | 2006 | 107 | 0.220 |
Why?
|
| Urogenital Abnormalities | 2 | 2018 | 154 | 0.220 |
Why?
|
| Diseases in Twins | 3 | 2017 | 86 | 0.220 |
Why?
|
| Length of Stay | 5 | 2020 | 1398 | 0.220 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3357 | 0.220 |
Why?
|
| Lignin | 1 | 2025 | 20 | 0.220 |
Why?
|
| Free Radical Scavengers | 1 | 2025 | 54 | 0.220 |
Why?
|
| Neck | 2 | 2019 | 140 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 93 | 0.220 |
Why?
|
| Spinal Dysraphism | 2 | 2019 | 254 | 0.210 |
Why?
|
| Morbidity | 2 | 2023 | 257 | 0.210 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5158 | 0.210 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2020 | 39 | 0.210 |
Why?
|
| Respiratory Insufficiency | 4 | 2014 | 242 | 0.210 |
Why?
|
| Coccyx | 1 | 2004 | 2 | 0.210 |
Why?
|
| Intestinal Atresia | 1 | 2024 | 22 | 0.210 |
Why?
|
| Sacrum | 1 | 2004 | 28 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 139 | 0.200 |
Why?
|
| Swine Diseases | 2 | 2014 | 40 | 0.200 |
Why?
|
| Wound Infection | 1 | 2024 | 58 | 0.200 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 254 | 0.200 |
Why?
|
| Osteomyelitis | 1 | 2006 | 209 | 0.200 |
Why?
|
| Intestinal Obstruction | 2 | 2017 | 86 | 0.200 |
Why?
|
| Burns | 1 | 2024 | 90 | 0.200 |
Why?
|
| Fibrosis | 3 | 2026 | 417 | 0.200 |
Why?
|
| Anesthesia, General | 2 | 2017 | 143 | 0.200 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2023 | 20 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 4713 | 0.200 |
Why?
|
| Ohio | 1 | 2023 | 85 | 0.200 |
Why?
|
| Intestine, Small | 3 | 2019 | 290 | 0.200 |
Why?
|
| Amniotic Fluid | 2 | 2015 | 145 | 0.190 |
Why?
|
| Colon | 1 | 2026 | 363 | 0.190 |
Why?
|
| Reference Values | 3 | 2014 | 675 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 324 | 0.190 |
Why?
|
| Neuroblastoma | 1 | 2008 | 543 | 0.190 |
Why?
|
| Appendectomy | 1 | 2023 | 88 | 0.190 |
Why?
|
| Universities | 1 | 2023 | 127 | 0.190 |
Why?
|
| Decision Support Techniques | 2 | 2015 | 292 | 0.190 |
Why?
|
| Splenectomy | 1 | 2022 | 61 | 0.190 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2022 | 10 | 0.180 |
Why?
|
| Rabbits | 1 | 2023 | 573 | 0.180 |
Why?
|
| Child, Preschool | 14 | 2018 | 14946 | 0.180 |
Why?
|
| Cells, Cultured | 5 | 2017 | 2895 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 526 | 0.180 |
Why?
|
| Risk Factors | 8 | 2020 | 10944 | 0.180 |
Why?
|
| Pain Management | 1 | 2024 | 204 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2024 | 4670 | 0.180 |
Why?
|
| Registries | 3 | 2014 | 1610 | 0.180 |
Why?
|
| Fatal Outcome | 3 | 2015 | 356 | 0.170 |
Why?
|
| Extracellular Matrix | 2 | 2026 | 232 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 471 | 0.170 |
Why?
|
| Hemoglobins | 1 | 2022 | 286 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 452 | 0.170 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 14 | 0.170 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2020 | 11 | 0.160 |
Why?
|
| Intestinal Absorption | 3 | 2017 | 170 | 0.160 |
Why?
|
| Delivery, Obstetric | 3 | 2013 | 257 | 0.160 |
Why?
|
| Choledocholithiasis | 1 | 2020 | 13 | 0.160 |
Why?
|
| Diaphragm | 1 | 2021 | 100 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2898 | 0.160 |
Why?
|
| Bile Acids and Salts | 2 | 2020 | 260 | 0.160 |
Why?
|
| Hernia | 2 | 2019 | 14 | 0.160 |
Why?
|
| Lactose | 2 | 2018 | 55 | 0.160 |
Why?
|
| Inflammation | 3 | 2017 | 1483 | 0.160 |
Why?
|
| Ultrasonography | 5 | 2015 | 950 | 0.160 |
Why?
|
| Catheterization | 4 | 2018 | 225 | 0.160 |
Why?
|
| Fetofetal Transfusion | 2 | 2015 | 203 | 0.150 |
Why?
|
| Emergency Treatment | 1 | 2020 | 82 | 0.150 |
Why?
|
| Specialties, Surgical | 1 | 2021 | 90 | 0.150 |
Why?
|
| Career Mobility | 1 | 2020 | 51 | 0.150 |
Why?
|
| Triglycerides | 3 | 2019 | 602 | 0.150 |
Why?
|
| Adolescent | 16 | 2019 | 20705 | 0.150 |
Why?
|
| Ileum | 2 | 2017 | 109 | 0.150 |
Why?
|
| Mice | 8 | 2026 | 18215 | 0.150 |
Why?
|
| Hospital Mortality | 4 | 2020 | 1059 | 0.150 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 31 | 0.150 |
Why?
|
| Tissue Expansion Devices | 1 | 2018 | 10 | 0.140 |
Why?
|
| Lymphatic Abnormalities | 1 | 2019 | 35 | 0.140 |
Why?
|
| Insulin | 3 | 2021 | 1140 | 0.140 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2020 | 172 | 0.140 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 6 | 0.140 |
Why?
|
| Clostridium | 1 | 2018 | 17 | 0.140 |
Why?
|
| Caspase 3 | 1 | 2018 | 122 | 0.140 |
Why?
|
| Gammaproteobacteria | 1 | 2018 | 14 | 0.140 |
Why?
|
| Bacillus | 1 | 2018 | 36 | 0.140 |
Why?
|
| Serum Amyloid A Protein | 2 | 2015 | 23 | 0.140 |
Why?
|
| Drainage | 2 | 2017 | 247 | 0.140 |
Why?
|
| Amino Acids | 1 | 2021 | 561 | 0.140 |
Why?
|
| Tretinoin | 1 | 2018 | 95 | 0.130 |
Why?
|
| Kupffer Cells | 1 | 2017 | 20 | 0.130 |
Why?
|
| Urinary Bladder Diseases | 1 | 2017 | 26 | 0.130 |
Why?
|
| Anesthesia | 1 | 2020 | 208 | 0.130 |
Why?
|
| Sciatic Nerve | 1 | 2017 | 57 | 0.130 |
Why?
|
| Endotoxins | 1 | 2017 | 51 | 0.130 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 106 | 0.130 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2017 | 30 | 0.130 |
Why?
|
| Recurrence | 1 | 2021 | 1470 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2018 | 124 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2011 | 934 | 0.130 |
Why?
|
| Gastroschisis | 2 | 2016 | 57 | 0.130 |
Why?
|
| Echocardiography, Doppler | 2 | 2011 | 159 | 0.130 |
Why?
|
| Age Factors | 2 | 2018 | 2829 | 0.130 |
Why?
|
| Nerve Regeneration | 1 | 2017 | 65 | 0.130 |
Why?
|
| Insufflation | 1 | 2017 | 17 | 0.130 |
Why?
|
| Young Adult | 11 | 2019 | 9977 | 0.130 |
Why?
|
| Fetal Development | 1 | 2018 | 121 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2018 | 494 | 0.130 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 47 | 0.130 |
Why?
|
| Eating | 1 | 2019 | 375 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 170 | 0.130 |
Why?
|
| Hydrogels | 1 | 2017 | 91 | 0.130 |
Why?
|
| Neoplasms | 1 | 2012 | 2966 | 0.130 |
Why?
|
| Citrulline | 1 | 2018 | 123 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 154 | 0.130 |
Why?
|
| Cesarean Section | 4 | 2013 | 422 | 0.120 |
Why?
|
| Physician's Role | 1 | 2018 | 164 | 0.120 |
Why?
|
| Time Factors | 6 | 2015 | 6196 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 294 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2020 | 279 | 0.120 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 48 | 0.120 |
Why?
|
| Genitalia | 1 | 2016 | 39 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2017 | 235 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2026 | 3829 | 0.120 |
Why?
|
| Perineum | 1 | 2016 | 40 | 0.120 |
Why?
|
| Developing Countries | 1 | 2018 | 301 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 209 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2017 | 235 | 0.120 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 108 | 0.120 |
Why?
|
| Animal Nutritional Physiological Phenomena | 2 | 2021 | 66 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 2569 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 550 | 0.120 |
Why?
|
| Phospholipids | 1 | 2016 | 99 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2023 | 6433 | 0.120 |
Why?
|
| Choristoma | 1 | 2016 | 44 | 0.120 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 65 | 0.120 |
Why?
|
| Arginine | 1 | 2018 | 337 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 345 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2017 | 813 | 0.120 |
Why?
|
| Pancreas | 3 | 2019 | 219 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 157 | 0.110 |
Why?
|
| Autopsy | 1 | 2015 | 113 | 0.110 |
Why?
|
| Survivors | 1 | 2018 | 345 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2017 | 444 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 2063 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2017 | 275 | 0.110 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2015 | 39 | 0.110 |
Why?
|
| Cell Count | 1 | 2015 | 214 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 4025 | 0.110 |
Why?
|
| Health Status Indicators | 1 | 2015 | 111 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2015 | 110 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 1073 | 0.110 |
Why?
|
| Hypercapnia | 1 | 2015 | 22 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2021 | 1061 | 0.110 |
Why?
|
| Sternum | 1 | 2015 | 50 | 0.110 |
Why?
|
| Respiratory Therapy | 1 | 2014 | 19 | 0.110 |
Why?
|
| Body Temperature | 1 | 2015 | 126 | 0.110 |
Why?
|
| Emulsions | 3 | 2021 | 69 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 169 | 0.110 |
Why?
|
| Vitamin E | 1 | 2015 | 62 | 0.110 |
Why?
|
| Laser Therapy | 2 | 2015 | 241 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 437 | 0.110 |
Why?
|
| Head | 1 | 2015 | 111 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1610 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 110 | 0.110 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 33 | 0.110 |
Why?
|
| Hospitalization | 1 | 2023 | 1930 | 0.110 |
Why?
|
| Tidal Volume | 1 | 2014 | 42 | 0.110 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 110 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 890 | 0.100 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2017 | 262 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3795 | 0.100 |
Why?
|
| Esophagus | 2 | 2014 | 231 | 0.100 |
Why?
|
| Biopsy | 2 | 2008 | 1244 | 0.100 |
Why?
|
| Risk | 2 | 2016 | 721 | 0.100 |
Why?
|
| Patient Participation | 1 | 2016 | 248 | 0.100 |
Why?
|
| Bronchi | 1 | 2014 | 98 | 0.100 |
Why?
|
| Amniotic Band Syndrome | 1 | 2013 | 25 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 430 | 0.100 |
Why?
|
| Informed Consent | 1 | 2016 | 350 | 0.100 |
Why?
|
| Critical Illness | 1 | 2018 | 621 | 0.100 |
Why?
|
| Horses | 1 | 2013 | 93 | 0.100 |
Why?
|
| Epidermis | 1 | 2013 | 61 | 0.100 |
Why?
|
| Uterine Rupture | 1 | 2013 | 15 | 0.100 |
Why?
|
| Sodium Glutamate | 1 | 2013 | 6 | 0.100 |
Why?
|
| Vocal Cords | 1 | 2013 | 61 | 0.100 |
Why?
|
| Patient Selection | 2 | 2019 | 719 | 0.100 |
Why?
|
| Counseling | 2 | 2014 | 234 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 256 | 0.100 |
Why?
|
| Mediastinal Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Placenta | 2 | 2015 | 498 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 1216 | 0.100 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2013 | 49 | 0.100 |
Why?
|
| Infant Mortality | 3 | 2020 | 181 | 0.090 |
Why?
|
| Gastric Emptying | 1 | 2013 | 78 | 0.090 |
Why?
|
| Play and Playthings | 1 | 2012 | 14 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 436 | 0.090 |
Why?
|
| Nutritional Support | 1 | 2013 | 67 | 0.090 |
Why?
|
| Resuscitation | 1 | 2015 | 276 | 0.090 |
Why?
|
| Glutamic Acid | 1 | 2013 | 193 | 0.090 |
Why?
|
| Postnatal Care | 1 | 2012 | 51 | 0.090 |
Why?
|
| Endoscopy | 1 | 2014 | 266 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2013 | 1483 | 0.090 |
Why?
|
| Laryngoscopy | 1 | 2013 | 158 | 0.090 |
Why?
|
| Polymers | 1 | 2012 | 104 | 0.090 |
Why?
|
| Isomerism | 1 | 2011 | 23 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 31 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 121 | 0.090 |
Why?
|
| Jugular Veins | 1 | 2011 | 71 | 0.090 |
Why?
|
| Catheters | 1 | 2012 | 83 | 0.090 |
Why?
|
| Mesentery | 1 | 2011 | 26 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2011 | 65 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 2012 | 96 | 0.090 |
Why?
|
| Lymphangioma, Cystic | 1 | 2011 | 16 | 0.090 |
Why?
|
| Linear Models | 1 | 2013 | 686 | 0.090 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2012 | 86 | 0.090 |
Why?
|
| Elasticity | 1 | 2011 | 97 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 291 | 0.080 |
Why?
|
| Ovotesticular Disorders of Sex Development | 1 | 2011 | 2 | 0.080 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 115 | 0.080 |
Why?
|
| Fetal Weight | 1 | 2011 | 64 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2018 | 1152 | 0.080 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2010 | 2 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 1286 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 204 | 0.080 |
Why?
|
| Sepsis | 1 | 2015 | 495 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 107 | 0.080 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2017 | 113 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 296 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 785 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 829 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 774 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2011 | 229 | 0.080 |
Why?
|
| Patient Transfer | 1 | 2011 | 109 | 0.080 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 58 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 535 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1376 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 417 | 0.080 |
Why?
|
| Muscle Proteins | 2 | 2023 | 400 | 0.080 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 160 | 0.080 |
Why?
|
| Nephrectomy | 2 | 2008 | 156 | 0.080 |
Why?
|
| Digestion | 1 | 2009 | 42 | 0.080 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2009 | 21 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2013 | 488 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2013 | 449 | 0.070 |
Why?
|
| Phenotype | 3 | 2025 | 4470 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2011 | 205 | 0.070 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2009 | 10 | 0.070 |
Why?
|
| Microsatellite Instability | 1 | 2009 | 38 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2012 | 217 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2021 | 1216 | 0.070 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2011 | 157 | 0.070 |
Why?
|
| Teaching | 1 | 2010 | 198 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1663 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 461 | 0.070 |
Why?
|
| Logistic Models | 1 | 2013 | 1793 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2008 | 900 | 0.070 |
Why?
|
| Parents | 1 | 2016 | 1107 | 0.070 |
Why?
|
| Research | 1 | 2010 | 264 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2008 | 29 | 0.070 |
Why?
|
| Base Pairing | 1 | 2008 | 40 | 0.070 |
Why?
|
| Receptors, Drug | 1 | 2008 | 27 | 0.070 |
Why?
|
| Mediastinal Cyst | 1 | 2007 | 8 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2008 | 36 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2008 | 73 | 0.070 |
Why?
|
| Ischemia | 1 | 2011 | 359 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2008 | 58 | 0.070 |
Why?
|
| Thrombelastography | 1 | 2008 | 69 | 0.070 |
Why?
|
| Vacuum | 1 | 2007 | 12 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 145 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2008 | 176 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2008 | 282 | 0.060 |
Why?
|
| Age Distribution | 1 | 2008 | 422 | 0.060 |
Why?
|
| Suction | 1 | 2007 | 49 | 0.060 |
Why?
|
| Codon, Nonsense | 1 | 2008 | 138 | 0.060 |
Why?
|
| Pressure | 1 | 2007 | 120 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 327 | 0.060 |
Why?
|
| Olive Oil | 2 | 2019 | 24 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2463 | 0.060 |
Why?
|
| Dyspnea | 1 | 2008 | 159 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2011 | 558 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 192 | 0.060 |
Why?
|
| Perinatal Mortality | 2 | 2017 | 44 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 192 | 0.060 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2006 | 3 | 0.060 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 146 | 0.060 |
Why?
|
| Comorbidity | 1 | 2011 | 1583 | 0.060 |
Why?
|
| Pulmonary Blastoma | 1 | 2006 | 11 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 263 | 0.060 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2007 | 133 | 0.060 |
Why?
|
| Actins | 1 | 2008 | 315 | 0.060 |
Why?
|
| Cause of Death | 1 | 2008 | 502 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 2025 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2008 | 315 | 0.060 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2006 | 84 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2005 | 230 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2334 | 0.060 |
Why?
|
| Tetralogy of Fallot | 1 | 2007 | 169 | 0.060 |
Why?
|
| Vascular Remodeling | 1 | 2025 | 46 | 0.060 |
Why?
|
| Pulmonary Emphysema | 1 | 2006 | 95 | 0.050 |
Why?
|
| Gallbladder Diseases | 1 | 2004 | 26 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 95 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1921 | 0.050 |
Why?
|
| Nephroma, Mesoblastic | 1 | 2004 | 7 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2024 | 30 | 0.050 |
Why?
|
| Neutrophils | 1 | 2005 | 361 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2023 | 65 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 535 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 636 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2008 | 922 | 0.050 |
Why?
|
| Carotid Artery, Common | 1 | 2023 | 59 | 0.050 |
Why?
|
| Heart Failure | 2 | 2014 | 2323 | 0.050 |
Why?
|
| Financing, Organized | 1 | 2022 | 21 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 185 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2023 | 124 | 0.050 |
Why?
|
| Abortion, Induced | 2 | 2013 | 88 | 0.050 |
Why?
|
| Placentation | 2 | 2015 | 59 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 82 | 0.050 |
Why?
|
| Growth and Development | 1 | 2021 | 20 | 0.040 |
Why?
|
| Edema | 1 | 2022 | 132 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 102 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 141 | 0.040 |
Why?
|
| Knowledge | 1 | 2021 | 48 | 0.040 |
Why?
|
| Tracheostomy | 2 | 2015 | 210 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 585 | 0.040 |
Why?
|
| Body Weight | 2 | 2017 | 983 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 3712 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2022 | 228 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2019 | 1109 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 160 | 0.040 |
Why?
|
| Personnel Management | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 176 | 0.040 |
Why?
|
| Program Development | 1 | 2021 | 182 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 79 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2551 | 0.040 |
Why?
|
| Staff Development | 1 | 2020 | 48 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1486 | 0.040 |
Why?
|
| Middle Aged | 4 | 2013 | 28369 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 437 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2019 | 85 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Infant Care | 1 | 2019 | 45 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 563 | 0.040 |
Why?
|
| Parturition | 1 | 2019 | 66 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 142 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 118 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 547 | 0.030 |
Why?
|
| Radiography | 2 | 2012 | 741 | 0.030 |
Why?
|
| Animal Feed | 1 | 2018 | 79 | 0.030 |
Why?
|
| Urodynamics | 1 | 2017 | 33 | 0.030 |
Why?
|
| MEDLINE | 1 | 2017 | 18 | 0.030 |
Why?
|
| Birth Weight | 1 | 2019 | 343 | 0.030 |
Why?
|
| Hindlimb | 1 | 2017 | 72 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 322 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2017 | 54 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 80 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 261 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 442 | 0.030 |
Why?
|
| Micelles | 1 | 2017 | 18 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2019 | 238 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 72 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 382 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 396 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 248 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 378 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 310 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2016 | 27 | 0.030 |
Why?
|
| Dogs | 1 | 2017 | 616 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 32 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 1113 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2017 | 83 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 543 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 759 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 82 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 304 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 18 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 789 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2018 | 268 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 1456 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1104 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 693 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 318 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 49 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2014 | 32 | 0.030 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 165 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 869 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 34 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 229 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2016 | 373 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 2014 | 52 | 0.030 |
Why?
|
| Animals, Inbred Strains | 1 | 2013 | 5 | 0.030 |
Why?
|
| Catheter Obstruction | 1 | 2013 | 8 | 0.020 |
Why?
|
| Microvilli | 1 | 2013 | 62 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 78 | 0.020 |
Why?
|
| Macrophages | 1 | 2017 | 661 | 0.020 |
Why?
|
| Caprylates | 1 | 2013 | 19 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2013 | 74 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2013 | 52 | 0.020 |
Why?
|
| Parity | 1 | 2013 | 77 | 0.020 |
Why?
|
| Oligohydramnios | 1 | 2013 | 45 | 0.020 |
Why?
|
| Absorption | 1 | 2012 | 49 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 222 | 0.020 |
Why?
|
| Reoperation | 1 | 2016 | 814 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2012 | 15 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 176 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 701 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2013 | 80 | 0.020 |
Why?
|
| Stillbirth | 1 | 2013 | 96 | 0.020 |
Why?
|
| Vasoplegia | 1 | 2012 | 19 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2012 | 27 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 104 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1016 | 0.020 |
Why?
|
| Stomach | 1 | 2014 | 270 | 0.020 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 58 | 0.020 |
Why?
|
| Water | 1 | 2012 | 185 | 0.020 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2011 | 6 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 2011 | 12 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 143 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1206 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1444 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 93 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 205 | 0.020 |
Why?
|
| Hemangioendothelioma | 1 | 2011 | 24 | 0.020 |
Why?
|
| Fetal Monitoring | 1 | 2011 | 58 | 0.020 |
Why?
|
| Isochromosomes | 1 | 2011 | 17 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2011 | 59 | 0.020 |
Why?
|
| Syndrome | 1 | 2013 | 1157 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2011 | 52 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 828 | 0.020 |
Why?
|
| Family | 1 | 2014 | 584 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 131 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 72 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 558 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2011 | 179 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 536 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2011 | 147 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 167 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 1314 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2009 | 15 | 0.020 |
Why?
|
| alpha-Glucosidases | 1 | 2009 | 33 | 0.020 |
Why?
|
| Pilonidal Sinus | 1 | 2009 | 2 | 0.020 |
Why?
|
| Lactase | 1 | 2009 | 42 | 0.020 |
Why?
|
| Galactose | 1 | 2009 | 53 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 140 | 0.020 |
Why?
|
| Fasciotomy | 1 | 2009 | 25 | 0.020 |
Why?
|
| Intestinal Fistula | 1 | 2009 | 22 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Heart Atria | 1 | 2012 | 336 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2009 | 34 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2009 | 84 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2009 | 69 | 0.020 |
Why?
|
| Mosaicism | 1 | 2011 | 247 | 0.020 |
Why?
|
| Leucovorin | 1 | 2009 | 53 | 0.020 |
Why?
|
| Infant Formula | 1 | 2009 | 105 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2009 | 146 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2009 | 132 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2013 | 601 | 0.020 |
Why?
|
| Pneumonia | 1 | 2012 | 340 | 0.020 |
Why?
|
| Abdominal Injuries | 1 | 2009 | 119 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 539 | 0.020 |
Why?
|
| Sulfonylurea Receptors | 1 | 2008 | 12 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 132 | 0.020 |
Why?
|
| Track and Field | 1 | 2007 | 1 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2009 | 125 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 305 | 0.020 |
Why?
|
| Glucagon | 1 | 2008 | 146 | 0.020 |
Why?
|
| Career Choice | 1 | 2009 | 167 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2008 | 147 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 169 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 240 | 0.020 |
Why?
|
| Pleurisy | 1 | 2006 | 6 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 125 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2008 | 183 | 0.020 |
Why?
|
| Laryngeal Diseases | 1 | 2006 | 28 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 545 | 0.010 |
Why?
|
| Pneumothorax | 1 | 2006 | 79 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 937 | 0.010 |
Why?
|
| Glucose | 1 | 2009 | 852 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 387 | 0.010 |
Why?
|
| Hypertension, Renal | 1 | 2004 | 30 | 0.010 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2004 | 13 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 2004 | 41 | 0.010 |
Why?
|
| Hematuria | 1 | 2004 | 48 | 0.010 |
Why?
|
| Ureter | 1 | 2004 | 84 | 0.010 |
Why?
|
| Forecasting | 1 | 2000 | 349 | 0.010 |
Why?
|
| Mortality | 1 | 2000 | 259 | 0.010 |
Why?
|
| Stroke | 1 | 2006 | 1056 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 6782 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 20862 | 0.010 |
Why?
|